Synaptogenix, Inc. (SNPX)
NASDAQ: SNPX · IEX Real-Time Price · USD
4.490
+0.090 (2.05%)
At close: Jul 19, 2024, 12:00 AM
4.310
-0.180 (-4.01%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Synaptogenix Employees
Synaptogenix had 5 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,445,316
Market Cap
5.54M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 5 | 0 | - |
| Dec 31, 2022 | 5 | 1 | 25.00% |
| Dec 31, 2021 | 4 | 0 | - |
| Dec 31, 2020 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Leafly Holdings | 131 |
| PolyPid | 62 |
| Biomerica | 62 |
| ENDRA Life Sciences | 21 |
| BioCardia | 20 |
| FSD Pharma | 17 |
| Aethlon Medical | 14 |
| TransCode Therapeutics | 10 |
SNPX News
- 4 days ago - Synaptogenix Announces New Collaboration with LSU Health New Orleans for Study of Proprietary Analogs in Spinal Cord Injury - PRNewsWire
- 26 days ago - Synaptogenix Announces FDA Authorization of IND Application for Clinical Trial for Bryostatin-1 in Multiple Sclerosis - PRNewsWire
- 2 months ago - Synaptogenix Applauds DEA Proposal to Reclassify Cannabis and Shares Expected Benefits to Cannasoul for Cannabinoid-Based Drug Discovery - PRNewsWire
- 3 months ago - Synaptogenix Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing - PRNewsWire
- 3 months ago - Synaptogenix Announces Reverse Stock Split to Maintain Nasdaq Listing - PRNewsWire
- 7 months ago - Synaptogenix President Daniel L. Alkon, M.D. - PRNewsWire
- 8 months ago - Synaptogenix Joins Leading Neuroscientists and Academics as Speaker at USC-Sponsored Forum on Age-Related Diseases including Alzheimer's - PRNewsWire
- 9 months ago - Synaptogenix Acquires Significant Stake in Cannasoul Analtyics Ltd. Co-founded by The Technion - Israel Institute of Technology - PRNewsWire